Diaphragmatic hernia in neonate.
During the last four years, we treated 41 infants with congenital diaphragmatic hernia with an overall survival rate of 68%. All infants presenting after the first day of life survived and the survival rate of neonates treated during the first day of life was 63%. The infants could be classified into two groups. In the first group infants did not have severe respiratory distress and had small diaphragmatic defects which were easily repaired with a survival rate of 95%. Neonates in the second group had severe respiratory distress or large lesions which were difficult to repair and a survival rate of only 30%.
D002245:Carbon Dioxide / Q000097:blood; D004298:Dopamine / Q000627:therapeutic use; D006548:Hernia, Diaphragmatic / Q000601:surgery; D065630:Hernias, Diaphragmatic, Congenital; D006801:Humans; D007231:Infant, Newborn; D010100:Oxygen / Q000097:blood; D011183:Postoperative Complications / Q000188:drug therapy / Q000401:mortality; D011379:Prognosis; D012121:Respiration, Artificial; D012127:Respiratory Distress Syndrome, Newborn / Q000401:mortality; D012306:Risk; D014043:Tolazoline / Q000627:therapeutic use
D002245:Carbon Dioxide; D014043:Tolazoline; D010100:Oxygen; D004298:Dopamine